Interview, Fireside Chat
Bryan Johnson: I Just Took the Most Powerful Dose of DMT in the World... Here's What It Was Like
- Psychedelics like psilocybin and 5-MeO-DMT are expected to transition from mental health treatments to "rejuvenation protocols" for anti-aging, with psilocybin anticipated to induce a "metabolic reset" shifting brain blood glucose to the top 99.9 percentile of the population and 5-MeO-DMT predicted to fully deactivate the default mode network to restore childlike states.
- The duration of 5-MeO-DMT's neuro-restorative effects, such as reduced internal chatter, is projected to persist beyond the immediate experience but may require repetition; while specific decay curves remain unknown, the effects could last 30 to 60 days or longer.
- A mitochondrial rejuvenation project is scheduled to begin with a blood draw within the next week or two to collect mitochondrial donors from a maternal relative, with the goal of using young mitochondria to counteract DNA degradation and potentially enable performance metrics like sprinting scores via intramuscular injection.
- Plans include constructing a facility to replicate FOXO3 plasmid-based tissue regeneration over a two-year period, a timeline that could be accelerated by employing AI as a project manager.
- New Limit's computational discovery of Yamanaka factors is expected to accelerate significantly beyond initial projections, with a future solution to cancer risks involving "cellular switches" that regulate protein synthesis in real-time based on gene expression.
- Longevity medicine is projected to evolve from GLP-1 injections being the "first big drop" to plasmid-based FOXO3 therapies demonstrating dramatic real-life changes, while induced pluripotent stem cell (iPSC) organoids will be used to simulate drug effects and determine safety profiles prior to human administration.
- Long-term societal shifts anticipate a move away from viewing longevity as a luxury for the wealthy toward a reality of abundant health and reduced conflict, with psychedelics serving as a "snapback" mechanism to maintain a youthful disposition and ambition in individuals over 50.
- Risks include potential permanent psychosis for individuals predisposed to schizophrenia or those using unsupervised, unquantified doses, as well as behavioral disruptions such as relationship breakdowns or professional abandonment due to dramatic perspective shifts.